Allergan plc (NYSE:AGN)

173.18
Delayed Data
As of Jun 15
 -0.77 / -0.44%
Today’s Change
142.81
Today|||52-Week Range
256.80
+5.87%
Year-to-Date
Allergan (AGN) Presents Positive Data on Glaucoma Candidate
Jun 14 / Zacks.com - Paid Partner Content
Amgen's (AMGN) Prolia Gets Label Expansion Approval in Europe
Jun 11 / Zacks.com - Paid Partner Content
Analysts Remain Bullish on Flexion Therapeutics
Jun 12 / GuruFocus News - Paid Partner Content
Pharma Stock Roundup: MRK Impresses at ASCO, LLY Gets FDA Nod for Olumiant
Jun 08 / Zacks.com - Paid Partner Content
Allergan's Second Anti-CGRP Drug Positive in Mid-Stage Study
Jun 12 / Zacks.com - Paid Partner Content
Allergan Requests Shareholders to Veto Management Change
Jun 06 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close173.95
Today’s open173.75
Day’s range171.88 - 174.22
Volume3,819,333
Average volume (3 months)3,206,721
Market cap$52.3B
Data as of 4:02pm ET, 06/15/2018

Growth & Valuation

Earnings growth (last year)-134.55%
Earnings growth (this year)-2.09%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+9.40%
P/E ratioNM
Price/Sales3.43
Price/Book0.74

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.07-0.19%
LLYEli Lilly and Co+0.53+0.61%
ABTAbbott Laboratories-0.05-0.08%
NVONovo Nordisk+0.19+0.43%
Data as of 4:04pm ET, 06/15/2018

Financials

Next reporting dateAugust 22, 2018
EPS forecast (this quarter)$4.08
Annual revenue (last year)$15.9B
Annual profit (last year)-$4.1B
Net profit margin-23.35%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Executive Vice President-
Global Operations
Wayne R. Swanton
Corporate headquarters
Dublin, Dublin

Forecasts